The Psychedelic Boom Could be Bigger than Cannabis

The psychedelics boom may be even more profitable than cannabis. Granted, such drugs have been written off for years. But that may not be the case for much longer.  With many like LSD, MDMA, and psilocybin showing promise for treating a range of mental and health conditions, including obsessive-compulsive disorder, PTSD, opioid addiction, alcoholism, eating … Continue reading The Psychedelic Boom Could be Bigger than Cannabis

Aurora Cannabis Rockets on CBD deal to enter the U.S. market

Aurora Cannabis is rocketing this morning on news it struck a deal to enter the U.S. cannabis market after buying CBD company, Reliva.  “It’s immediate access into the world’s largest cannabinoid market,” Aurora Executive Chairman and interim CEO Michael Singer, as quoted by CNBC. “I think the Reliva acquisition is a responsible strategic entry into the … Continue reading Aurora Cannabis Rockets on CBD deal to enter the U.S. market

Telehealth Boom Could Create $175 Billion Opportunity by 2026

With the coronavirus making its rounds, telemedicine is under big demand. All as government and health officials advise against face to face meetings.  It’s becoming so popular Global Market Insights estimates the market could be worth $175 billion by 2026. Markets and Markets estimates telehealth could grow from $25.4 billion in 2020 to more than … Continue reading Telehealth Boom Could Create $175 Billion Opportunity by 2026

The Top 3 Moments from the Berkshire Hathaway Meeting

“Nothing can stop America.” That was Warren Buffett’s firm message at Berskshire’s 2020 annual shareholder meeting. Some of the key highlights at the meeting included: “Nothing can stop America” “The American miracle, the American magic has always prevailed, and it will do so again. … In World War II, I was convinced of this,” he … Continue reading The Top 3 Moments from the Berkshire Hathaway Meeting

Moderna (MRNA) Advances to Next Stage of Vaccine Testing

We may be nearing a coronavirus vaccine. Just yesterday, Moderna (MRNA) announced it submitted an Investigational New Drug (IND) application to the US FDA for its mRNA candidate to “evaluate mRNA-1273 in Phase 2 and late-stage studies if supported by safety data from the Phase 1 study led by the National Institute of Allergy and … Continue reading Moderna (MRNA) Advances to Next Stage of Vaccine Testing

IBM Beats Estimates, But Forced to Pull Full-Year Guidance

Shares of IBM slipped in afterhours trading. Not only did it report a pullback in first quarter revenue, in pulled its annual forecast. “Looking at the first quarter, through February we were tracking roughly in-line with our expectations,” said Chief Financial Officer James Kavanaugh as quoted by MarketWatch. “As we got into March, the health … Continue reading IBM Beats Estimates, But Forced to Pull Full-Year Guidance

re: WTF – Today’s New Alert (MGNX) Goes from approx $22 to $32 (Want Another?)

WTF! “Wow That Flew” Today’s New Alert (MGNX) Sky-Rockets From approx $22 to $32! Hello Trader, This morning pre-market, I alerted SWN’s SMS Text Group to keep a close eye on MacroGenics & Novelion Therapeutics Inc. Both companies released gangbuster news that ignited share prices to absolutely sky-rocket in price this morning. When my SMS was sent out pre-market … Continue reading re: WTF – Today’s New Alert (MGNX) Goes from approx $22 to $32 (Want Another?)